Annis Gardner Whiting Capital Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,100
Closed -$149K – 890
2026
Q1
$149K Buy
2,100
+988
+89% +$74K 0.02% 364
2025
Q4
$87.8K Buy
1,112
+4
+0.4% +$317 0.02% 431
2025
Q3
$91.3K Sell
1,108
-31
-3% -$2.44K 0.02% 409
2025
Q2
$91.6K Sell
1,139
-44
-4% -$3.4K 0.03% 310
2025
Q1
$95K Sell
1,183
-13
-1% -$1.08K 0.04% 282
2024
Q4
$97.9K Buy
1,196
+263
+28% +$21.9K 0.03% 279
2024
Q3
$77K Sell
933
-14
-1% -$1.05K 0.02% 321
2024
Q2
$66.5K Buy
947
+590
+165% +$42.1K 0.02% 367
2024
Q1
$26.5K Buy
357
+71
+25% +$4.95K 0.01% 490
2023
Q4
$18.9K Buy
286
+8
+3% +$501 0.01% 412
2023
Q3
$17.5K Buy
+278
New +$17.3K 0.01% 410

Other funds holding MET

Annis Gardner Whiting Capital Advisors's MET Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of MetLife (MET) in Q2 2026, closing a stake of 2,100 shares — an estimated $149K sold.

Annis Gardner Whiting Capital Advisors first reported a position in MET in Q3 2023 and held it in 11 quarters. The position peaked at $149K in Q1 2026. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 2,100 MetLife shares in Q2 2026, an estimated $149K.
  • Annis Gardner Whiting Capital Advisors first reported a position in MetLife in Q3 2023 and held it in 11 quarters.
  • Annis Gardner Whiting Capital Advisors's MetLife position peaked at $149K in Q1 2026.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.